Marriott Harrison advises Accel and XTX Ventures on their Pre-Series A Investment into Turbine

Monday 18th January, 2021

The team at MH were delighted to advise Accel and XTX Ventures as they co-led the Pre-Series A Investment into Turbine.

Turbine successfully raised €5.7M in the round, which also included new investor, Boston Millenia Partners, and existing investors Delin Ventures, Atlantic Labs and o2h Ventures.

The company develops an AI-enabled cell simulation technology to understand the complex biology of cancer. With the help of the Simulated Cell™, the team discovers novel targets, which have better chances of turning into clinical success than targets tested with wet-lab methods. This funding will be used to help Turbine advance its simulation-based pipeline to tackle the highest unmet needs in oncology.

The team at MH was led by David Strong and included David Bettis, Sofia Gottgens, Ed Belam, Alex Lee and Ben Cole.